Effect of high-intensity interval training on aerobic capacity and fatigue among patients with prostate cancer: a meta-analysis

Table 1 Basic information included in the studies

Study	Age (y)	PSA (μg/L)	Duration	HIIT program	CON program	Equipment	Index
Baguley 2022 [9]	65.9±7.8	HIIT: 1.3±1.2 CON: 1.0±1.3	8 weeks; 3x/week	4 sets×(4min 95%HR_peak: 3min 70%HR_peak)	Usual care	ergometer	VO_2peak; fatigue
Djurhuus 2022 [14]	HIIT: 62.5±2.9 CON: 66.8±2.6	HIIT: 11.8±11.8 CON: 15.7±13.9	8 weeks; 4x/week	6 sets×(1min 120%W_peak: 3min 30%W_peak)	Usual care	ergometer	VO_2peak; IL-6; TNF-α; PSA
Kang 2021 [15]	HIIT: 63.9±7.5 CON: 62.8±6.9	HIIT: 6.0±2.3 CON: 8.6±3.5	12 weeks; 3x/week	8 sets×(2min 95%VO_2peak: 5min 40%VO_2peak)	Usual care	treadmill	VO_2peak; PSA
Kang 2022 [16]	HIIT: 63.9±7.5 CON: 62.8±6.9	HIIT: 6.0±2.3 CON: 8.6±3.5	12 weeks; 3x/week	8 sets×(2min 95%VO_2peak: 5min 40%VO_2peak)	Usual care	treadmill	Fatigue
Papadopoulos 2021 [13]	HIIT: 62.0±10.4 CON: 62.1±3.2	HIIT: 4.2±2.3 CON: 5.3±2.3	8 weeks; 2x/week	10 sets×(1min 85%HR_peak: 1min 15W)	Usual care	ergometer	VO_2peak; IL-6; TNF-α
Piraux 2020 [12]	HIIT: 67.4±8.9 CON: 67.9±7.1	NR	8 weeks; 3x/week	15 sets×(1min 85%HR_peak: 1min 60%HR_peak)	Usual care	ergometer	Fatigue

PSA prostate-specific antigen, NR not reported, HR_peak peak heart rate, W_peak peak power, VO_2peak peak oxygen uptake, IL-6 interleukin-6, TNF-α tumor necrosis factor-α, HIIT high-intensity interval training

ISSN: 1477-7819